These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10969787)
1. Growth inhibition of prostate cancer by an adenovirus expressing a novel tumor suppressor gene, pHyde. Steiner MS; Zhang X; Wang Y; Lu Y Cancer Res; 2000 Aug; 60(16):4419-25. PubMed ID: 10969787 [TBL] [Abstract][Full Text] [Related]
2. Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence. Steiner MS; Zhang Y; Farooq F; Lerner J; Wang Y; Lu Y Cancer Gene Ther; 2000 Mar; 7(3):360-72. PubMed ID: 10766342 [TBL] [Abstract][Full Text] [Related]
3. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis. Matsubara S; Wada Y; Gardner TA; Egawa M; Park MS; Hsieh CL; Zhau HE; Kao C; Kamidono S; Gillenwater JY; Chung LW Cancer Res; 2001 Aug; 61(16):6012-9. PubMed ID: 11507044 [TBL] [Abstract][Full Text] [Related]
4. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Zhang WW; Fang X; Mazur W; French BA; Georges RN; Roth JA Cancer Gene Ther; 1994 Mar; 1(1):5-13. PubMed ID: 7621238 [TBL] [Abstract][Full Text] [Related]
5. Recombinant adenovirus vector expressing wild-type p53 is a potent inhibitor of prostate cancer cell proliferation. Srivastava S; Katayose D; Tong YA; Craig CR; McLeod DG; Moul JW; Cowan KH; Seth P Urology; 1995 Dec; 46(6):843-8. PubMed ID: 7502427 [TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated p53 gene therapy inhibits human sarcoma tumorigenicity. Milas M; Yu D; Lang A; Ge T; Feig B; El-Naggar AK; Pollock RE Cancer Gene Ther; 2000 Mar; 7(3):422-9. PubMed ID: 10766348 [TBL] [Abstract][Full Text] [Related]
7. Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines. Lee SE; Jin RJ; Lee SG; Yoon SJ; Park MS; Heo DS; Choi H Anticancer Res; 2000; 20(1A):417-22. PubMed ID: 10769689 [TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer. Xie X; Zhao X; Liu Y; Zhang J; Matusik RJ; Slawin KM; Spencer DM Cancer Res; 2001 Sep; 61(18):6795-804. PubMed ID: 11559553 [TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer. Shariat SF; Desai S; Song W; Khan T; Zhao J; Nguyen C; Foster BA; Greenberg N; Spencer DM; Slawin KM Cancer Res; 2001 Mar; 61(6):2562-71. PubMed ID: 11289132 [TBL] [Abstract][Full Text] [Related]
10. Role of pHyde novel gene product as an intrinsic factor for apoptotic pathway in prostate cancer. Rinaldy AR; Menon RP; Lerner JL; Steiner MS Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():215-22. PubMed ID: 10895157 [TBL] [Abstract][Full Text] [Related]
11. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo. Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255 [TBL] [Abstract][Full Text] [Related]
12. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene. Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530 [TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice. Lee J; Wang A; Hu Q; Lu S; Dong Z Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978 [TBL] [Abstract][Full Text] [Related]
14. PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression. Xu LL; Shi Y; Petrovics G; Sun C; Makarem M; Zhang W; Sesterhenn IA; McLeod DG; Sun L; Moul JW; Srivastava S Cancer Res; 2003 Aug; 63(15):4299-304. PubMed ID: 12907594 [TBL] [Abstract][Full Text] [Related]
15. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells. Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756 [TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer. Li X; Marani M; Yu J; Nan B; Roth JA; Kagawa S; Fang B; Denner L; Marcelli M Cancer Res; 2001 Jan; 61(1):186-91. PubMed ID: 11196158 [TBL] [Abstract][Full Text] [Related]
17. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase. Igawa T; Lin FF; Rao P; Lin MF Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404 [TBL] [Abstract][Full Text] [Related]
18. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor. Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890 [TBL] [Abstract][Full Text] [Related]
19. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice. Xu X; Kreye E; Kuo CB; Walker AM Cancer Res; 2001 Aug; 61(16):6098-104. PubMed ID: 11507059 [TBL] [Abstract][Full Text] [Related]
20. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1). Katner AL; Hoang QB; Gootam P; Jaruga E; Ma Q; Gnarra J; Rayford W Prostate; 2002 Sep; 53(1):77-87. PubMed ID: 12210483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]